Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Savita Bisht

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Oncology Research and Treatment|October 1, 2018
Novel Targets in Pancreatic Cancer Therapy - Current Status and Ongoing Translational EffortsSavita Bisht, Georg Feldmann
Expert Opinion on Drug Discovery|January 19, 2019
Animal models for modeling pancreatic cancer and novel drug discoverySavita Bisht, Georg Feldmann
Current Drug Discovery Technologies|June 6, 2009
Systemic delivery of curcumin: 21st century solutions for an ancient conundrumSavita Bisht, Anirban Maitra
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|January 6, 2010
Dextran-doxorubicin/chitosan nanoparticles for solid tumor therapySavita Bisht, Amarnath Maitra
Expert Opinion on Drug Metabolism & Toxicology|April 18, 2013
Pharmacokinetics and pharmacodynamics of sunitinib for the treatment of advanced pancreatic neuroendocrine tumorsSavita Bisht, Georg Feldmann, Peter Brossart
Oncology Research and Treatment|October 5, 2018
Current Therapeutic Options for Pancreatic Ductal AdenocarcinomaSavita Bisht, Peter Brossart, Georg Feldmann
Current Opinion in Investigational Drugs (London, England : 2000)|December 15, 2010
Agents targeting the Hedgehog pathway for pancreatic cancer treatmentSavita Bisht, Peter Brossart, Anirban Maitra, et al.
International Journal of Pharmaceutics|December 21, 2004
pDNA loaded calcium phosphate nanoparticles: highly efficient non-viral vector for gene deliverySavita Bisht, Gajadhar Bhakta, Susmita Mitra, et al.
Expert Opinion on Drug Discovery|June 1, 2012
Recent developments of transgenic and xenograft mouse models of pancreatic cancer for translational researchUte Schütte, Savita Bisht, Peter Brossart, et al.
Expert Opinion on Pharmacotherapy|August 10, 2012
Everolimus for the treatment of pancreatic neuroendocrine tumorsGeorg Feldmann, Savita Bisht, Ute Schütte, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Oncology Research and Treatment|October 1, 2018
Novel Targets in Pancreatic Cancer Therapy - Current Status and Ongoing Translational EffortsSavita Bisht, Georg Feldmann
Expert Opinion on Drug Discovery|January 19, 2019
Animal models for modeling pancreatic cancer and novel drug discoverySavita Bisht, Georg Feldmann
Current Drug Discovery Technologies|June 6, 2009
Systemic delivery of curcumin: 21st century solutions for an ancient conundrumSavita Bisht, Anirban Maitra
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|January 6, 2010
Dextran-doxorubicin/chitosan nanoparticles for solid tumor therapySavita Bisht, Amarnath Maitra
Expert Opinion on Drug Metabolism & Toxicology|April 18, 2013
Pharmacokinetics and pharmacodynamics of sunitinib for the treatment of advanced pancreatic neuroendocrine tumorsSavita Bisht, Georg Feldmann, Peter Brossart
Oncology Research and Treatment|October 5, 2018
Current Therapeutic Options for Pancreatic Ductal AdenocarcinomaSavita Bisht, Peter Brossart, Georg Feldmann
Current Opinion in Investigational Drugs (London, England : 2000)|December 15, 2010
Agents targeting the Hedgehog pathway for pancreatic cancer treatmentSavita Bisht, Peter Brossart, Anirban Maitra, et al.
International Journal of Pharmaceutics|December 21, 2004
pDNA loaded calcium phosphate nanoparticles: highly efficient non-viral vector for gene deliverySavita Bisht, Gajadhar Bhakta, Susmita Mitra, et al.
Expert Opinion on Drug Discovery|June 1, 2012
Recent developments of transgenic and xenograft mouse models of pancreatic cancer for translational researchUte Schütte, Savita Bisht, Peter Brossart, et al.
Expert Opinion on Pharmacotherapy|August 10, 2012
Everolimus for the treatment of pancreatic neuroendocrine tumorsGeorg Feldmann, Savita Bisht, Ute Schütte, et al.
Pageof 4